Rejected Drug Could Protect Against Parkinson's And Alzheimer's
09:00 EDT 13 Aug 2012 | Medical News Today
The journal Molecular Psychiatry recently featured two studies on latrepirdine, known as Dimebon, which revealed that the second study could be a new potential for the compound to treat Parkinson's, Alzheimer's disease, sleep disorders as well as oth..
Original Article: Rejected Drug Could Protect Against Parkinson's And Alzheimer's
More From BioPortfolio on "Rejected Drug Could Protect Against Parkinson's And Alzheimer's"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
